TABLE 4.
Comparison of baseline characteristics between pre-implementation and post-implementation periods.
| Characteristic | Pre-implementation (Jan–Dec 2024, n = 2,975) |
Post-implementation (Jan–Jun 2025, n = 1,522) |
Statistical test | P-value |
|---|---|---|---|---|
| Age (years) | 59.8 ± 15.2 | 60.4 ± 14.9 | t = -1.234 | 0.217 |
| Sex, male, n (%) | 1,389 (46.7) | 724 (47.6) | χ2 = 0.312 | 0.576 |
| Primary diagnosis, n (%) | χ2 = 2.456 | 0.873 | ||
| - Lung cancer | 892 (30.0) | 456 (30.0) | ||
| - Colorectal cancer | 654 (22.0) | 334 (21.9) | ||
| - Gastric cancer | 445 (15.0) | 228 (15.0) | ||
| - Other malignancies | 984 (33.1) | 504 (33.1) | ||
| APACHE II score | 18.5 ± 5.2 | 18.7 ± 5.1 | t = -1.156 | 0.248 |
| Comorbidities, n (%) | ||||
| - Diabetes mellitus | 654 (22.0) | 335 (22.0) | χ2 = 0.001 | 0.978 |
| - Chronic kidney disease | 297 (10.0) | 152 (10.0) | χ2 = 0.001 | 0.975 |
| - Chronic heart failure | 446 (15.0) | 229 (15.0) | χ2 = 0.003 | 0.954 |
| ICU length of stay (days), median (IQR) | 3.4 (2.0–6.2) | 3.2 (1.9–5.9) | Z = -1.567 | 0.117 |
No patient was included in both periods. All baseline characteristics were extracted from electronic medical records for the full populations in each period. SD, standard deviation; IQR, interquartile range; APACHE II, Acute Physiology and Chronic Health Evaluation II.